Displaying 261 - 266 of 266 Results
Blog Toxic Exposure

Fifth Circuit soundly rules but BP wrench-throwing continues | Causes, Not Just Cases®

September 16, 2014 | by: Joseph F. Rice
Next week will mark eight months since claims payments through the Deepwater Horizon Settlement’s Business Economic Loss program were halted due to an October 2013 Fifth Circuit Court of Appeals ruling in which Judge Barbier was instructed to craft a “narrowly-tailored injunction” that subsequently stopped payouts.
Blog Toxic Exposure

Supreme Court allows BEL claims to proceed | Causes, Not Just Cases®

September 16, 2014 | by: Joseph F. Rice
Good news came today for claimants in the Deepwater Horizon litigation when the U.S. Supreme Court refused BP’s request to block payments under the Business and Economic Loss (BEL) Settlement Agreement while the Court considers whether or not it will review BP’s challenge of that settlement’s terms.
Blog Personal Injury Lawsuits

10 seconds may save your summer vacation | Causes, Not Just Cases®

September 16, 2014 | by: Kevin R. Dean
It may take a couple extra seconds out of your summer vacation time this year, but taking a few small steps to ensure your family’s safety while on the road or during your vacation stay could save you from some mishaps down the road.
Blog Medical Drugs | Medical Device Lawsuits | Women’s Health Lawsuits

Is there a link between talcum powder and cancer? | Causes, Not Just Cases®

September 16, 2014 | by: Carmen S. Scott
While studies continue to examine talcum powder and ovarian cancer, women of all ages should be aware that concerns about the possible relationship between the genital application of talcum powder and ovarian cancer are starting to gain attention.
Blog Medical Device Lawsuits

Morcellator warning only the latest reason FDA should consider revising the 510(k) process | Causes, Not Just Cases®

September 16, 2014 | by: Carmen S. Scott
When the FDA released a safety communication earlier this year about the laparoscopic power morcellation (LPM) procedure, many women may have been shocked to learn that this fairly common procedure for removing supposedly benign uterine fibroids could result in the rapid spread of cancer if those fibroids turned out…
Blog Medical Drugs

Generic Drug Labeling: Brand-name drug manufacturers can be held liable for warnings on generic versions | Causes, Not Just Cases®

September 16, 2014 | by: Fred Thompson III
The controversial Wyeth v. Weeks decision, which was confirmed by the Alabama Supreme Court this past August 15, 2014, provided a welcome ray of hope in a preemption landscape made desolate by the Mensing decision of 2011.